Impulse Dynamics Opens its Hong Kong Sales and Support Office

Hong Kong, China – January 11th, 2016 – Impulse Dynamics NV (Impulse), the developer of the Optimizer™ IVs implantable device, is pleased to announce the official opening of its Hong Kong sales and support office. The Optimizer IVs is a minimally invasive implantable device designed to treat heart failure.  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses to the heart muscle.

“I am proud and excited to bring Impulse Dynamics’ innovative chronic heart failure treatment CCM direct to the Hong Kong market” said Vilana Chan, Impulse’s Sales and Marketing Manager, who leads the Hong Kong office.

“Impulse continues to make good progress on all fronts. 2015 saw Impulse and CCM break into 6 new territories. Early in 2016 we are opening our first office in Asia. I personally look forward to supporting Vilana and our Hong Kong customers and patients” says Impulse CEO Simos Kedikoglou.  “CCM is a technology that meets a major clinical need to improve performance and daily life of patients with heart failure that are not adequately controlled with pharmaceutical treatment alone, and we are committed to expanding its global introduction to benefit more patients.”

About the Optimizer™ IVs System and CCM Therapy

The Optimizer IVs device which delivers CCM therapy has been successfully launched in Europe and other international markets and is available in a growing number of cardiology centers around the world. The therapy has been implanted in about 3,000 patients to date and is the only device therapy available for patients with narrow QRS complex. Impulse Dynamics has completed a vast number of clinical studies, including several randomized controlled trials, as published in over 60 publications in leading medical journals. The Optimizer IVs is limited to investigational use in the USA.

About Impulse Dynamics

Impulse Dynamics N.V. is focused on the development of electrical therapies for the treatment of chronic heart failure.  As a global leader in cardiac medical innovation, Impulse Dynamics has operations in the US, Europe, Asia and Australia.  For more information please visit

Impulse Dynamics (HK) LIMITED
3109 Tower 2
Lippo Centre
89 Queensway
Hong Kong